Cargando…

BI2536, a potent and selective inhibitor of polo-like kinase 1, in combination with cisplatin exerts synergistic effects on gastric cancer cells

BI2536 is a highly selective and potent inhibitor of polo-like kinase 1 (PLK1). In this study, we aimed to determine whether BI2536 and cisplatin can synergistically inhibit the malignant behavior of gastric cancer cells. For this purpose, the expression of PLK1 in gastric cancer cells was determine...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lian, Guodong, Li, Leping, Shi, Yulong, Jing, Changqing, Liu, Jinglei, Guo, Xiaobo, Zhang, Qingqing, Dai, Tianyu, Ye, Fei, Wang, Yanyan, Chen, Man
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2018
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5807034/ https://www.ncbi.nlm.nih.gov/pubmed/29393385 http://dx.doi.org/10.3892/ijo.2018.4255

Ejemplares similares

BI-2536 and BI-6727, dual Polo-like kinase/bromodomain inhibitors, effectively reactivate latent HIV-1
por: Gohda, Jin, et al.
Publicado: (2018)

Polo‑like kinase 1 selective inhibitor BI2536 (dihydropteridinone) disrupts centrosome homeostasis via ATM‑ERK cascade in adrenocortical carcinoma
por: Lin, Ruei-Ci, et al.
Publicado: (2023)

BI 2536 induces gasdermin E-dependent pyroptosis in ovarian cancer
por: Huo, Jianting, et al.
Publicado: (2022)

BI2536 induces mitotic catastrophe and radiosensitization in human oral cancer cells
por: Cheng, Chieh-Yuan, et al.
Publicado: (2018)

Pharmacological inhibition of Polo-like kinase 1 (PLK1) by BI-2536 decreases the viability and survival of hamartin and tuberin deficient cells via induction of apoptosis and attenuation of autophagy
por: Valianou, Matthildi, et al.
Publicado: (2015)

BI-2536 Promotes Neuroblastoma Cell Death via Minichromosome Maintenance Complex Components 2 and 10
por: Hsieh, Chiao-Hui, et al.
Publicado: (2021)

The Plk1 Inhibitor BI 2536 Temporarily Arrests Primary Cardiac Fibroblasts in Mitosis and Generates Aneuploidy In Vitro
por: Lu, Bo, et al.
Publicado: (2010)

Observation of D$_{s}^{** }$(2536) meson production by neutrinos in BEBC
por: Asratyan, A E, et al.
Publicado: (1993)

A randomised phase II trial of the Polo-like kinase inhibitor BI 2536 in chemo-naïve patients with unresectable exocrine adenocarcinoma of the pancreas – a study within the Central European Society Anticancer Drug Research (CESAR) collaborative network
por: Mross, K, et al.
Publicado: (2012)

Observation of the decays $ {B}_{(s)}^0 $ → D$_{s1}$(2536)$^{∓}$K$^{±}$
por: Aaij, Roel, et al.
Publicado: (2023)

D+_s1(2536) Production in Hadronic Z0 Decays
por: CERN. Geneva
Publicado: (1996)

The dual role of BI 2536, a small-molecule inhibitor that targets PLK1, in induction of apoptosis and attenuation of autophagy in neuroblastoma cells
por: Li, Zhiheng, et al.
Publicado: (2020)

Study of the Decay Bs0 → Ds+1(2536) µ−νµ at the LHCb
por: Sellam, Sara
Publicado: (2019)

$D_{J}^{(*)0}$ and $D_{s1}^{+}(2536)$ production in hadronic $Z^{0}$ decays
por: Krieger, P
Publicado: (1997)

2536. Evaluation of Anticipatory Guidance Provided by Internal Medicine Residents for the Care of Patients with Fever
por: Rubio, Luis, et al.
Publicado: (2019)

MCC1019, a selective inhibitor of the Polo-box domain of Polo-like kinase 1 as novel, potent anticancer candidate
por: Abdelfatah, Sara, et al.
Publicado: (2019)

Adjuvant TNF-α therapy to electrochemotherapy with intravenous cisplatin in murine sarcoma exerts synergistic antitumor effectiveness
por: Cemazar, Maja, et al.
Publicado: (2015)

Combination Treatment With Remdesivir and Ivermectin Exerts Highly Synergistic and Potent Antiviral Activity Against Murine Coronavirus Infection
por: Tan, Yu Ling, et al.
Publicado: (2021)

Impacts of the mTOR gene polymorphisms rs2536 and rs2295080 on breast cancer risk in the Chinese population
por: Zhao, Yang, et al.
Publicado: (2016)

Comprehensive analysis of the effect of rs2295080 and rs2536 polymorphisms within the mTOR gene on cancer risk
por: Qi, Guang-Hui, et al.
Publicado: (2020)

PB2536: ACETAMINOPHEN AND CHLORPHENIRAMINE MALEATE PREMEDICATION IN PATIENTS WITH CHRONIC TRANSFUSION: A PROSPECTIVE, RANDOMIZED CONTROLLED TRIAL
por: Janyangam, Supanat, et al.
Publicado: (2023)

Polo club /
por: Fuster, Gabriel
Publicado: (2010)

Los polos
por: Ley, Willy, 1906-1969
Publicado: (1963)

Marco Polo /
por: Collis, Maurice, 1889-1973
Publicado: (1984)

Marco Polo
por: Collis, Maurice, 1889-1973
Publicado: (1984)

Marco Polo
por: Collis, Maurice, 1889-1973
Publicado: (1955)

Marco Polo
por: Heers, Jacques
Publicado: (1985)

Marco Polo
por: Collis, Maurice, 1889-1973
Publicado: (1966)

Marco Polo
por: Shklovski, Viktor, 1893-1984

Marco Polo
por: Collis, Maurice, 1889-1973
Publicado: (1992)

Arsenic trioxide exerts synergistic effects with cisplatin on non-small cell lung cancer cells via apoptosis induction
por: Li, Hecheng, et al.
Publicado: (2009)

Decitabine and Cisplatin are Synergistic to Exert Anti-Tumor Effect on Gastric Cancer via Inducing Sox2 DNA Demethylation
por: Zhu, Zhipeng, et al.
Publicado: (2021)

The BET bromodomain inhibitor exerts the most potent synergistic anticancer effects with quinone-containing compounds and anti-microtubule drugs
por: Liu, Pei Y., et al.
Publicado: (2016)

2536: The effect of skeletal muscle lipoprotein lipase overexpression on energy expenditure during weight loss maintenance and weight regain
por: Presby, David M., et al.
Publicado: (2018)

BI6727, a polo-like kinase 1 inhibitor with promising efficacy on Burkitt lymphoma cells
por: Chen, Er, et al.
Publicado: (2020)

Polo-like kinase in trypanosomes: an odd member out of the Polo family
por: Kurasawa, Yasuhiro, et al.
Publicado: (2020)

Combination of cisplatin and bromelain exerts synergistic cytotoxic effects against breast cancer cell line MDA-MB-231 in vitro
por: Pauzi, Ahmad Zaim Mat, et al.
Publicado: (2016)

DHODH Inhibition Exerts Synergistic Therapeutic Effect with Cisplatin to Induce Ferroptosis in Cervical Cancer through Regulating mTOR Pathway
por: Jiang, Mengying, et al.
Publicado: (2023)

2536. Comparing the activity of broad-spectrum beta-lactams in combination with aminoglycosides and aztreonam/avibactam against 8 VIM-producing CRE
por: Clark, Justin A, et al.
Publicado: (2023)

The polo-like kinase 1 inhibitor volasertib synergistically increases radiation efficacy in glioma stem cells
por: Dong, Jianwen, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_faqi3mol4n906qenh16nnfdbqe